 | • レポートコード：MRC2-11QY12163 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はB型・C型肝炎診断のグローバル市場について調査・分析したレポートです。種類別（B型肝炎、C型肝炎）市場規模、用途別（免疫診断、核酸検査（NAT））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別B型・C型肝炎診断の競争状況、市場シェア ・世界のB型・C型肝炎診断市場：種類別市場規模 2015年-2020年（B型肝炎、C型肝炎） ・世界のB型・C型肝炎診断市場：種類別市場規模予測 2021年-2026年（B型肝炎、C型肝炎） ・世界のB型・C型肝炎診断市場：用途別市場規模 2015年-2020年（免疫診断、核酸検査（NAT）） ・世界のB型・C型肝炎診断市場：用途別市場規模予測 2021年-2026年（免疫診断、核酸検査（NAT）） ・北米のB型・C型肝炎診断市場分析：米国、カナダ ・ヨーロッパのB型・C型肝炎診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのB型・C型肝炎診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のB型・C型肝炎診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのB型・C型肝炎診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Diagnostics、Abbott、Siemens、Qiagen、Abbott、bioMérieux、Cepheid、Chembio Diagnostics、DiaSorin、Enzo Life Sciences、Hologic、MedMira、OraSure Technologies、Quest Diagnostics、Quidel Corp、Randox Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.
The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.
Market Analysis and Insights: Global Hepatitis B and C Diagnostics Market
The global Hepatitis B and C Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hepatitis B and C Diagnostics Scope and Market Size
Hepatitis B and C Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B and C Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche Diagnostics
Abbott
Siemens
Qiagen
Abbott
bioMérieux
Cepheid
Chembio Diagnostics
DiaSorin
Enzo Life Sciences
Hologic
MedMira
OraSure Technologies
Quest Diagnostics
Quidel Corp
Randox Laboratories
Market segment by Type, the product can be split into
Hepatitis B
Hepatitis C
Market segment by Application, split into
Immunodiagnostics
Nucleic Acid Test (NAT)
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hepatitis B and C Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hepatitis B
1.4.3 Hepatitis C
1.5 Market by Application
1.5.1 Global Hepatitis B and C Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Immunodiagnostics
1.5.3 Nucleic Acid Test (NAT)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B and C Diagnostics Market Perspective (2015-2026)
2.2 Global Hepatitis B and C Diagnostics Growth Trends by Regions
2.2.1 Hepatitis B and C Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hepatitis B and C Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Hepatitis B and C Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hepatitis B and C Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Hepatitis B and C Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B and C Diagnostics Players by Market Size
3.1.1 Global Top Hepatitis B and C Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Hepatitis B and C Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Hepatitis B and C Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hepatitis B and C Diagnostics Market Concentration Ratio
3.2.1 Global Hepatitis B and C Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hepatitis B and C Diagnostics Revenue in 2019
3.3 Hepatitis B and C Diagnostics Key Players Head office and Area Served
3.4 Key Players Hepatitis B and C Diagnostics Product Solution and Service
3.5 Date of Enter into Hepatitis B and C Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hepatitis B and C Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hepatitis B and C Diagnostics Market Size by Application (2015-2020)
5.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hepatitis B and C Diagnostics Market Size (2015-2020)
6.2 Hepatitis B and C Diagnostics Key Players in North America (2019-2020)
6.3 North America Hepatitis B and C Diagnostics Market Size by Type (2015-2020)
6.4 North America Hepatitis B and C Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hepatitis B and C Diagnostics Market Size (2015-2020)
7.2 Hepatitis B and C Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Hepatitis B and C Diagnostics Market Size by Type (2015-2020)
7.4 Europe Hepatitis B and C Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Hepatitis B and C Diagnostics Market Size (2015-2020)
8.2 Hepatitis B and C Diagnostics Key Players in China (2019-2020)
8.3 China Hepatitis B and C Diagnostics Market Size by Type (2015-2020)
8.4 China Hepatitis B and C Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hepatitis B and C Diagnostics Market Size (2015-2020)
9.2 Hepatitis B and C Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Hepatitis B and C Diagnostics Market Size by Type (2015-2020)
9.4 Japan Hepatitis B and C Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hepatitis B and C Diagnostics Market Size (2015-2020)
10.2 Hepatitis B and C Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hepatitis B and C Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis B and C Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Hepatitis B and C Diagnostics Market Size (2015-2020)
11.2 Hepatitis B and C Diagnostics Key Players in India (2019-2020)
11.3 India Hepatitis B and C Diagnostics Market Size by Type (2015-2020)
11.4 India Hepatitis B and C Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hepatitis B and C Diagnostics Market Size (2015-2020)
12.2 Hepatitis B and C Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Hepatitis B and C Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Hepatitis B and C Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics Hepatitis B and C Diagnostics Introduction
13.1.4 Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Hepatitis B and C Diagnostics Introduction
13.2.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Siemens
13.3.1 Siemens Company Details
13.3.2 Siemens Business Overview
13.3.3 Siemens Hepatitis B and C Diagnostics Introduction
13.3.4 Siemens Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
13.3.5 Siemens Recent Development
13.4 Qiagen
13.4.1 Qiagen Company Details
13.4.2 Qiagen Business Overview
13.4.3 Qiagen Hepatitis B and C Diagnostics Introduction
13.4.4 Qiagen Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
13.4.5 Qiagen Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview
13.5.3 Abbott Hepatitis B and C Diagnostics Introduction
13.5.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 bioMérieux
13.6.1 bioMérieux Company Details
13.6.2 bioMérieux Business Overview
13.6.3 bioMérieux Hepatitis B and C Diagnostics Introduction
13.6.4 bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
13.6.5 bioMérieux Recent Development
13.7 Cepheid
13.7.1 Cepheid Company Details
13.7.2 Cepheid Business Overview
13.7.3 Cepheid Hepatitis B and C Diagnostics Introduction
13.7.4 Cepheid Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
13.7.5 Cepheid Recent Development
13.8 Chembio Diagnostics
13.8.1 Chembio Diagnostics Company Details
13.8.2 Chembio Diagnostics Business Overview
13.8.3 Chembio Diagnostics Hepatitis B and C Diagnostics Introduction
13.8.4 Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
13.8.5 Chembio Diagnostics Recent Development
13.9 DiaSorin
13.9.1 DiaSorin Company Details
13.9.2 DiaSorin Business Overview
13.9.3 DiaSorin Hepatitis B and C Diagnostics Introduction
13.9.4 DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
13.9.5 DiaSorin Recent Development
13.10 Enzo Life Sciences
13.10.1 Enzo Life Sciences Company Details
13.10.2 Enzo Life Sciences Business Overview
13.10.3 Enzo Life Sciences Hepatitis B and C Diagnostics Introduction
13.10.4 Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
13.10.5 Enzo Life Sciences Recent Development
13.11 Hologic
10.11.1 Hologic Company Details
10.11.2 Hologic Business Overview
10.11.3 Hologic Hepatitis B and C Diagnostics Introduction
10.11.4 Hologic Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
10.11.5 Hologic Recent Development
13.12 MedMira
10.12.1 MedMira Company Details
10.12.2 MedMira Business Overview
10.12.3 MedMira Hepatitis B and C Diagnostics Introduction
10.12.4 MedMira Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
10.12.5 MedMira Recent Development
13.13 OraSure Technologies
10.13.1 OraSure Technologies Company Details
10.13.2 OraSure Technologies Business Overview
10.13.3 OraSure Technologies Hepatitis B and C Diagnostics Introduction
10.13.4 OraSure Technologies Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
10.13.5 OraSure Technologies Recent Development
13.14 Quest Diagnostics
10.14.1 Quest Diagnostics Company Details
10.14.2 Quest Diagnostics Business Overview
10.14.3 Quest Diagnostics Hepatitis B and C Diagnostics Introduction
10.14.4 Quest Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
10.14.5 Quest Diagnostics Recent Development
13.15 Quidel Corp
10.15.1 Quidel Corp Company Details
10.15.2 Quidel Corp Business Overview
10.15.3 Quidel Corp Hepatitis B and C Diagnostics Introduction
10.15.4 Quidel Corp Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
10.15.5 Quidel Corp Recent Development
13.16 Randox Laboratories
10.16.1 Randox Laboratories Company Details
10.16.2 Randox Laboratories Business Overview
10.16.3 Randox Laboratories Hepatitis B and C Diagnostics Introduction
10.16.4 Randox Laboratories Revenue in Hepatitis B and C Diagnostics Business (2015-2020)
10.16.5 Randox Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hepatitis B and C Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Hepatitis B and C Diagnostics Revenue
Table 3. Ranking of Global Top Hepatitis B and C Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hepatitis B
Table 6. Key Players of Hepatitis C
Table 7. Global Hepatitis B and C Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hepatitis B and C Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hepatitis B and C Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hepatitis B and C Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Hepatitis B and C Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hepatitis B and C Diagnostics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hepatitis B and C Diagnostics Market Growth Strategy
Table 17. Main Points Interviewed from Key Hepatitis B and C Diagnostics Players
Table 18. Global Hepatitis B and C Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hepatitis B and C Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Hepatitis B and C Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B and C Diagnostics as of 2019)
Table 21. Global Hepatitis B and C Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hepatitis B and C Diagnostics Product Solution and Service
Table 24. Date of Enter into Hepatitis B and C Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hepatitis B and C Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hepatitis B and C Diagnostics Market Size Share by Type (2015-2020)
Table 28. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2021-2026)
Table 29. Global Hepatitis B and C Diagnostics Market Size Share by Application (2015-2020)
Table 30. Global Hepatitis B and C Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hepatitis B and C Diagnostics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hepatitis B and C Diagnostics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hepatitis B and C Diagnostics Market Share (2019-2020)
Table 34. North America Hepatitis B and C Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hepatitis B and C Diagnostics Market Share by Type (2015-2020)
Table 36. North America Hepatitis B and C Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hepatitis B and C Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Key Players Hepatitis B and C Diagnostics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hepatitis B and C Diagnostics Market Share (2019-2020)
Table 40. Europe Hepatitis B and C Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hepatitis B and C Diagnostics Market Share by Type (2015-2020)
Table 42. Europe Hepatitis B and C Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hepatitis B and C Diagnostics Market Share by Application (2015-2020)
Table 44. China Key Players Hepatitis B and C Diagnostics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hepatitis B and C Diagnostics Market Share (2019-2020)
Table 46. China Hepatitis B and C Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. China Hepatitis B and C Diagnostics Market Share by Type (2015-2020)
Table 48. China Hepatitis B and C Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. China Hepatitis B and C Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Key Players Hepatitis B and C Diagnostics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hepatitis B and C Diagnostics Market Share (2019-2020)
Table 52. Japan Hepatitis B and C Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hepatitis B and C Diagnostics Market Share by Type (2015-2020)
Table 54. Japan Hepatitis B and C Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hepatitis B and C Diagnostics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hepatitis B and C Diagnostics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hepatitis B and C Diagnostics Market Share (2019-2020)
Table 58. Southeast Asia Hepatitis B and C Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hepatitis B and C Diagnostics Market Share by Type (2015-2020)
Table 60. Southeast Asia Hepatitis B and C Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hepatitis B and C Diagnostics Market Share by Application (2015-2020)
Table 62. India Key Players Hepatitis B and C Diagnostics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hepatitis B and C Diagnostics Market Share (2019-2020)
Table 64. India Hepatitis B and C Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. India Hepatitis B and C Diagnostics Market Share by Type (2015-2020)
Table 66. India Hepatitis B and C Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. India Hepatitis B and C Diagnostics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hepatitis B and C Diagnostics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hepatitis B and C Diagnostics Market Share (2019-2020)
Table 70. Central & South America Hepatitis B and C Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hepatitis B and C Diagnostics Market Share by Type (2015-2020)
Table 72. Central & South America Hepatitis B and C Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hepatitis B and C Diagnostics Market Share by Application (2015-2020)
Table 74. Roche Diagnostics Company Details
Table 75. Roche Diagnostics Business Overview
Table 76. Roche Diagnostics Product
Table 77. Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 78. Roche Diagnostics Recent Development
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Product
Table 82. Abbott Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 83. Abbott Recent Development
Table 84. Siemens Company Details
Table 85. Siemens Business Overview
Table 86. Siemens Product
Table 87. Siemens Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 88. Siemens Recent Development
Table 89. Qiagen Company Details
Table 90. Qiagen Business Overview
Table 91. Qiagen Product
Table 92. Qiagen Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 93. Qiagen Recent Development
Table 94. Abbott Company Details
Table 95. Abbott Business Overview
Table 96. Abbott Product
Table 97. Abbott Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 98. Abbott Recent Development
Table 99. bioMérieux Company Details
Table 100. bioMérieux Business Overview
Table 101. bioMérieux Product
Table 102. bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 103. bioMérieux Recent Development
Table 104. Cepheid Company Details
Table 105. Cepheid Business Overview
Table 106. Cepheid Product
Table 107. Cepheid Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 108. Cepheid Recent Development
Table 109. Chembio Diagnostics Business Overview
Table 110. Chembio Diagnostics Product
Table 111. Chembio Diagnostics Company Details
Table 112. Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 113. Chembio Diagnostics Recent Development
Table 114. DiaSorin Company Details
Table 115. DiaSorin Business Overview
Table 116. DiaSorin Product
Table 117. DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 118. DiaSorin Recent Development
Table 119. Enzo Life Sciences Company Details
Table 120. Enzo Life Sciences Business Overview
Table 121. Enzo Life Sciences Product
Table 122. Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 123. Enzo Life Sciences Recent Development
Table 124. Hologic Company Details
Table 125. Hologic Business Overview
Table 126. Hologic Product
Table 127. Hologic Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 128. Hologic Recent Development
Table 129. MedMira Company Details
Table 130. MedMira Business Overview
Table 131. MedMira Product
Table 132. MedMira Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 133. MedMira Recent Development
Table 134. OraSure Technologies Company Details
Table 135. OraSure Technologies Business Overview
Table 136. OraSure Technologies Product
Table 137. OraSure Technologies Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 138. OraSure Technologies Recent Development
Table 139. Quest Diagnostics Company Details
Table 140. Quest Diagnostics Business Overview
Table 141. Quest Diagnostics Product
Table 142. Quest Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 143. Quest Diagnostics Recent Development
Table 144. Quidel Corp Company Details
Table 145. Quidel Corp Business Overview
Table 146. Quidel Corp Product
Table 147. Quidel Corp Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 148. Quidel Corp Recent Development
Table 149. Randox Laboratories Company Details
Table 150. Randox Laboratories Business Overview
Table 151. Randox Laboratories Product
Table 152. Randox Laboratories Revenue in Hepatitis B and C Diagnostics Business (2015-2020) (Million US$)
Table 153. Randox Laboratories Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B and C Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Hepatitis B Features
Figure 3. Hepatitis C Features
Figure 4. Global Hepatitis B and C Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Immunodiagnostics Case Studies
Figure 6. Nucleic Acid Test (NAT) Case Studies
Figure 7. Hepatitis B and C Diagnostics Report Years Considered
Figure 8. Global Hepatitis B and C Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Hepatitis B and C Diagnostics Market Share by Regions: 2020 VS 2026
Figure 10. Global Hepatitis B and C Diagnostics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Hepatitis B and C Diagnostics Market Share by Players in 2019
Figure 13. Global Top Hepatitis B and C Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B and C Diagnostics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Hepatitis B and C Diagnostics Revenue in 2019
Figure 15. North America Hepatitis B and C Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Hepatitis B and C Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Hepatitis B and C Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Hepatitis B and C Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Hepatitis B and C Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Hepatitis B and C Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Hepatitis B and C Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
E型肝炎診断検査の世界市場（～2026年） Hepatitis E is a virus that affects your liver. Market Analysis and Insights: Global Hepatitis E Diagnostic Tests Market The global Hepatitis E Diagnostic Tests market size is projected to reach US$ 43 million by 2026, from US$ 42 million in 2020, at a CAGR of 2.2%% during 2021-2026. Global Hepatiti…- 肝炎検査ソリューションの世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
- C型肝炎ウイルス（HCV）抗ウイルス剤の世界市場（～2026年） Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatit…
- 肝炎検査診断の世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
- B型肝炎検査の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis B Testing Market The global Hepatitis B Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis B Testing Scope and Market Size Hepatitis B Testing market is seg…